Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of MRP3 (unknown origin)
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of benzmarone-stimulated MRP3 ATPase activity (unknown origin) in presence of GSH
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of MRP3 (unknown origin) at 1 to 10 uM
Assay data:1 Tested
Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay
Assay data:5 Active, 629 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Activity of recombinant human ABCC3 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as transporter-mediated drug uptake per mg of protein by liquid scintillation counting analysis in presence of ATP
Activity of recombinant human ABCC3 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as transporter-mediated drug uptake by liquid scintillation counting analysis in presence of ATP
Activity of recombinant human ABCC3 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as transporter-mediated drug uptake at 10 uM by liquid scintillation counting analysis in presence of ATP
Inhibition of recombinant human ABCC3 expressed in baculovirus infected insect Sf21 cell plasma membrane vesicles assessed as inhibition of transporter-mediated [3H]-estradiol-17beta-glucuronide uptake by liquid scintillation counting analysis
Assay data:9 Active, 10 Tested
Inhibition of human MRP3-mediated estradiol-17beta-D-glucuronide formation using inside-out membrane vesicles by LC-MS/MS analysis
Assay data:1 Active, 2 Tested
Drug uptake assessed as human MRP3-mediated drug transport using inside-out membrane vesicles by measuring +ATP/-ATP ratio by LC-MS/MS analysis
Assay data:2 Tested
Inhibition of MRP3-mediated E2-17betaG transport in human MRP3 expressing HEK293 cells in presence of 15 uM E2-17betaG
Assay data:3 Active, 3 Tested
Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed phase-HPLC analysis in presence of GSH
Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of ATP
Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport after 10 mins by Michaelis-Menten plot analysis
Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM up to 20 mins by Michaelis-Menten plot analysis
Assay data:1 Active, 1 Tested
Activity at MRP3 (unknown origin) expressed in baculovirus-infected HEK293 cells assessed as drug transport at 400 uM after 10 mins by reversed-phase HPLC analysis in presence of AMP
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in doxorubicin accumulation after 24 hrs by spectrofluorometric analysis
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation at 0.5 to 5 uM after 24 hrs by spectrofluorometric analysis
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation at 25 uM after 24 hrs by spectrofluorometric analysis
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in doxorubicin accumulation at 5 uM after 24 hrs by spectrofluorometric analysis in presence of nitric oxide scavenger PTIO and RBCs
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on